WO2001068720A1 - Embolic compositions - Google Patents
Embolic compositions Download PDFInfo
- Publication number
- WO2001068720A1 WO2001068720A1 PCT/US2001/007940 US0107940W WO0168720A1 WO 2001068720 A1 WO2001068720 A1 WO 2001068720A1 US 0107940 W US0107940 W US 0107940W WO 0168720 A1 WO0168720 A1 WO 0168720A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- embolic composition
- embolic
- macromers
- composition
- groups
- Prior art date
Links
- 0 CCC1OC(*)(*N(*)*)OC(C)C1 Chemical compound CCC1OC(*)(*N(*)*)OC(C)C1 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L51/00—Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
- C08L51/003—Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers grafted on to macromolecular compounds obtained by reactions only involving unsaturated carbon-to-carbon bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12122—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder within the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/12186—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices liquid materials adapted to be injected
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/1219—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices expandable in contact with liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/12195—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices comprising a curable material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0031—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/041—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F261/00—Macromolecular compounds obtained by polymerising monomers on to polymers of oxygen-containing monomers as defined in group C08F16/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F261/00—Macromolecular compounds obtained by polymerising monomers on to polymers of oxygen-containing monomers as defined in group C08F16/00
- C08F261/02—Macromolecular compounds obtained by polymerising monomers on to polymers of oxygen-containing monomers as defined in group C08F16/00 on to polymers of unsaturated alcohols
- C08F261/04—Macromolecular compounds obtained by polymerising monomers on to polymers of oxygen-containing monomers as defined in group C08F16/00 on to polymers of unsaturated alcohols on to polymers of vinyl alcohol
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F271/00—Macromolecular compounds obtained by polymerising monomers on to polymers of nitrogen-containing monomers as defined in group C08F26/00
- C08F271/02—Macromolecular compounds obtained by polymerising monomers on to polymers of nitrogen-containing monomers as defined in group C08F26/00 on to polymers of monomers containing heterocyclic nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F277/00—Macromolecular compounds obtained by polymerising monomers on to polymers of carbocyclic or heterocyclic monomers as defined respectively in group C08F32/00 or in group C08F34/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F290/00—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F290/00—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
- C08F290/08—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated side groups
- C08F290/12—Polymers provided for in subclasses C08C or C08F
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F290/00—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups
- C08F290/08—Macromolecular compounds obtained by polymerising monomers on to polymers modified by introduction of aliphatic unsaturated end or side groups on to polymers modified by introduction of unsaturated side groups
- C08F290/14—Polymers provided for in subclass C08G
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L51/00—Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
- C08L51/08—Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers grafted on to macromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001567808A JP4871476B2 (en) | 2000-03-13 | 2001-03-13 | Embolization composition |
AU2001245660A AU2001245660B2 (en) | 2000-03-13 | 2001-03-13 | Embolic compositions |
DE60130544T DE60130544T2 (en) | 2000-03-13 | 2001-03-13 | EMBOLIC COMPOSITIONS |
AU4566001A AU4566001A (en) | 2000-03-13 | 2001-03-13 | Embolic compositions |
EP01918602A EP1263803B1 (en) | 2000-03-13 | 2001-03-13 | Embolic compositions |
CA2403218A CA2403218C (en) | 2000-03-13 | 2001-03-13 | Embolic compositions |
PCT/US2001/028809 WO2002072166A1 (en) | 2001-03-13 | 2001-09-12 | Compositions for drug delivery |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18897500P | 2000-03-13 | 2000-03-13 | |
US60/188,975 | 2000-03-13 | ||
US25469700P | 2000-12-11 | 2000-12-11 | |
US60/254,697 | 2000-12-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001068720A1 true WO2001068720A1 (en) | 2001-09-20 |
Family
ID=26884649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/007940 WO2001068720A1 (en) | 2000-03-13 | 2001-03-13 | Embolic compositions |
Country Status (8)
Country | Link |
---|---|
US (6) | US6676971B2 (en) |
EP (1) | EP1263803B1 (en) |
JP (1) | JP4871476B2 (en) |
AT (1) | ATE373682T1 (en) |
AU (2) | AU2001245660B2 (en) |
CA (1) | CA2403218C (en) |
DE (1) | DE60130544T2 (en) |
WO (1) | WO2001068720A1 (en) |
Cited By (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002009789A2 (en) * | 2000-08-02 | 2002-02-07 | Aesculap Ag & Co. Kg | Medical technical product, method for producing the same and providing the same for surgery |
WO2002072166A1 (en) * | 2001-03-13 | 2002-09-19 | Biocure, Inc. | Compositions for drug delivery |
US6713646B2 (en) | 2002-04-12 | 2004-03-30 | Biosphere Medical | Degradable crosslinkers, and degradable crosslinked hydrogels comprising them |
WO2004028569A1 (en) * | 2002-09-25 | 2004-04-08 | Biocompatibles Uk Limited | Polymer compositions for administration to animals |
WO2004071495A1 (en) * | 2003-02-12 | 2004-08-26 | Biocompatibles Uk Limited | Composition for chemoembolotherapy of solid tumors |
WO2004073688A1 (en) * | 2003-02-21 | 2004-09-02 | Biocompatibles Uk Limited | Drug delivery from embolic agents |
EP1460982A1 (en) * | 2001-11-16 | 2004-09-29 | BioCure, Inc. | Methods for initiating in situ formation of hydrogels |
WO2004087007A2 (en) * | 2003-03-25 | 2004-10-14 | Biocure, Inc. | Hydrogel string medical device |
WO2004091683A2 (en) * | 2003-04-11 | 2004-10-28 | Vascular Control Systems, Inc. | Embolic occlusion of uterine arteries |
WO2004096869A1 (en) * | 2003-04-29 | 2004-11-11 | Basf Corporation | Method for creating microsphere polymers and particles |
US6884905B2 (en) | 2002-07-23 | 2005-04-26 | Biosphere Medical | Degradable carbamate-containing bis(acryloyl) crosslinkers, and degradable crosslinked hydrogels comprising them |
WO2005087193A2 (en) * | 2004-03-11 | 2005-09-22 | Biocompatibles Uk Limited | Chemoembolisation involving an anthracycline compound |
DE102004014633A1 (en) * | 2004-03-22 | 2005-10-13 | Aesculap Ag & Co. Kg | Composition for adhesion prophylaxis |
WO2006013309A1 (en) * | 2004-08-03 | 2006-02-09 | Biocompatibles Uk Limited | Drug delivery from embolic agents |
WO2006026412A2 (en) * | 2004-08-31 | 2006-03-09 | Vnus Medical Technologies, Inc. | Apparatus and material composition for permanent occlusion of a hollow anatomical structure |
US7207996B2 (en) | 2002-04-04 | 2007-04-24 | Vascular Control Systems, Inc. | Doppler directed suturing and compression device and method |
WO2007085615A1 (en) * | 2006-01-24 | 2007-08-02 | Biocompatibles Uk Limited | Process for loading polymer particles with drug |
EP1824414A2 (en) * | 2004-11-16 | 2007-08-29 | MicroVention, Inc. | Compositions, systems and methods for treatment of defects in blood vessels |
WO2007142916A2 (en) | 2006-05-30 | 2007-12-13 | Incept, Llc | Materials formable in situ within a medical device |
US7442385B2 (en) * | 2003-02-12 | 2008-10-28 | Biocompatibles Uk Limited | Chemoembolisation |
WO2009046281A2 (en) * | 2007-10-05 | 2009-04-09 | Boston Scientific Scimed, Inc. | Injectable particles |
EP2484344A3 (en) * | 2005-05-09 | 2012-09-12 | Biosphere Medical, S.A. | Compositions and methods of using microspheres and non-ionic contrast agents |
JP2014039882A (en) * | 2003-03-24 | 2014-03-06 | Pluromed Inc | Temporary embolization using inverse thermosensitive polymers |
US8968353B2 (en) | 2005-01-25 | 2015-03-03 | Covidien Lp | Method and apparatus for impeding migration of an implanted occlusive structure |
US9017361B2 (en) | 2006-04-20 | 2015-04-28 | Covidien Lp | Occlusive implant and methods for hollow anatomical structure |
US9114200B2 (en) | 2009-09-24 | 2015-08-25 | Microvention, Inc. | Injectable hydrogel filaments for biomedical uses |
US9259228B2 (en) | 2006-06-15 | 2016-02-16 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US9381278B2 (en) | 2012-04-18 | 2016-07-05 | Microvention, Inc. | Embolic devices |
US9456823B2 (en) | 2011-04-18 | 2016-10-04 | Terumo Corporation | Embolic devices |
US9486221B2 (en) | 2007-12-21 | 2016-11-08 | Microvision, Inc. | Hydrogel filaments for biomedical uses |
CN106344968A (en) * | 2003-02-12 | 2017-01-25 | 生物相容英国有限公司 | Use of composition in manufacture of medicament for formation of embolism in circulatory system of patients with solid tumors during in embolotherapy |
WO2017037276A1 (en) * | 2015-09-03 | 2017-03-09 | Biocompatibles Uk Limited | Polymers and microspheres |
EP3199186A1 (en) * | 2016-01-28 | 2017-08-02 | Cook Medical Technologies LLC | Injectable compositions and methods of use thereof |
EP2667855B1 (en) * | 2011-01-27 | 2017-08-09 | Biocompatibles Uk Ltd. | Drug delivery systems |
CN107812232A (en) * | 2017-11-08 | 2018-03-20 | 华威(深圳)医疗器械有限责任公司 | Can be developed carboxy-modified polyvinyl alcohol microparticles suppository and its preparation technology |
US9993252B2 (en) | 2009-10-26 | 2018-06-12 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US10092663B2 (en) | 2014-04-29 | 2018-10-09 | Terumo Corporation | Polymers |
US10098972B2 (en) | 2013-09-06 | 2018-10-16 | Biocompatibles Uk Ltd. | Imageable polymers |
US10124090B2 (en) | 2014-04-03 | 2018-11-13 | Terumo Corporation | Embolic devices |
US10226533B2 (en) | 2014-04-29 | 2019-03-12 | Microvention, Inc. | Polymer filaments including pharmaceutical agents and delivering same |
US10265271B2 (en) | 2000-03-24 | 2019-04-23 | Biosphere Medical, Inc. | Microspheres for the treatment of a prostate hyperplasia by active embolization |
US10350295B2 (en) | 2013-09-06 | 2019-07-16 | Biocompatibles Uk Ltd. | Radiopaque polymers |
US10448955B2 (en) | 2006-01-30 | 2019-10-22 | Biosphere Medical, Inc. | Compressible intravascular embolization particles and related methods and delivery systems |
WO2020003147A2 (en) | 2018-06-29 | 2020-01-02 | Biocompatibles Uk Limited | Radiopaque polymers |
US10639396B2 (en) | 2015-06-11 | 2020-05-05 | Microvention, Inc. | Polymers |
WO2023287727A1 (en) | 2021-07-12 | 2023-01-19 | Boston Scientific Scimed, Inc. | Radiopaque compositions |
WO2023122292A1 (en) | 2021-12-23 | 2023-06-29 | Boston Scientific Medical Device Limited | Chemoembolic compositions and methods of treatment using them |
US11730865B2 (en) | 2018-05-15 | 2023-08-22 | Incept, Llc | Embolic compositions and methods |
Families Citing this family (150)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2784580B1 (en) | 1998-10-16 | 2004-06-25 | Biosepra Inc | POLYVINYL-ALCOHOL MICROSPHERES AND METHODS OF MAKING THE SAME |
JP4871476B2 (en) * | 2000-03-13 | 2012-02-08 | バイオコンパティブルズ ユーケー リミテッド | Embolization composition |
US6652883B2 (en) * | 2000-03-13 | 2003-11-25 | Biocure, Inc. | Tissue bulking and coating compositions |
US20030212022A1 (en) * | 2001-03-23 | 2003-11-13 | Jean-Marie Vogel | Compositions and methods for gene therapy |
US9080146B2 (en) * | 2001-01-11 | 2015-07-14 | Celonova Biosciences, Inc. | Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface |
EP1392175A2 (en) * | 2001-05-04 | 2004-03-03 | Concentric Medical | Hydrogel filament vaso-occlusive device |
US20030014075A1 (en) * | 2001-07-16 | 2003-01-16 | Microvention, Inc. | Methods, materials and apparatus for deterring or preventing endoleaks following endovascular graft implanation |
US20050267407A1 (en) * | 2002-02-01 | 2005-12-01 | Vascular Designs, Inc. | Multi-function catheter and use thereof |
WO2003065872A2 (en) * | 2002-02-01 | 2003-08-14 | Goldman Robert J | Multi-function catheter and use thereof |
US8062251B2 (en) * | 2002-02-01 | 2011-11-22 | Vascular Designs, Inc. | Multi-function catheter and use thereof |
US7462366B2 (en) | 2002-03-29 | 2008-12-09 | Boston Scientific Scimed, Inc. | Drug delivery particle |
US7105031B2 (en) * | 2002-04-26 | 2006-09-12 | Medtronic Vascular, Inc. | Balloon-tipped, multi-lumen catheter for endoluminal repair of endoluminal leaks in aortic or aorto-iliac endoluminal grafts |
US7838699B2 (en) * | 2002-05-08 | 2010-11-23 | Biosphere Medical | Embolization using degradable crosslinked hydrogels |
CA2492339A1 (en) | 2002-06-12 | 2003-12-24 | Boston Scientific Limited | Bulking agents |
US20080226723A1 (en) * | 2002-07-05 | 2008-09-18 | Celonova Biosciences, Inc. | Loadable Polymeric Particles for Therapeutic Use in Erectile Dysfunction and Methods of Preparing and Using the Same |
US7842377B2 (en) * | 2003-08-08 | 2010-11-30 | Boston Scientific Scimed, Inc. | Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient |
US8012454B2 (en) | 2002-08-30 | 2011-09-06 | Boston Scientific Scimed, Inc. | Embolization |
US7883490B2 (en) * | 2002-10-23 | 2011-02-08 | Boston Scientific Scimed, Inc. | Mixing and delivery of therapeutic compositions |
US7396540B2 (en) * | 2003-04-25 | 2008-07-08 | Medtronic Vascular, Inc. | In situ blood vessel and aneurysm treatment |
US7976823B2 (en) | 2003-08-29 | 2011-07-12 | Boston Scientific Scimed, Inc. | Ferromagnetic particles and methods |
AU2003272255A1 (en) * | 2003-09-02 | 2005-04-06 | University Of Florida | Polymeric reconstrainable, repositionable, detachable, percutaneous endovascular stentgraft |
US20050107867A1 (en) * | 2003-11-17 | 2005-05-19 | Taheri Syde A. | Temporary absorbable venous occlusive stent and superficial vein treatment method |
ES2396689T3 (en) | 2003-12-11 | 2013-02-25 | Isto Technologies Inc. | Particle Cartilage System |
US20050158272A1 (en) * | 2004-01-07 | 2005-07-21 | Trivascular, Inc. | Methods, compositions and devices for embolizing body lumens |
US8052669B2 (en) | 2004-02-25 | 2011-11-08 | Femasys Inc. | Methods and devices for delivery of compositions to conduits |
US8048101B2 (en) | 2004-02-25 | 2011-11-01 | Femasys Inc. | Methods and devices for conduit occlusion |
US8048086B2 (en) | 2004-02-25 | 2011-11-01 | Femasys Inc. | Methods and devices for conduit occlusion |
US9238127B2 (en) | 2004-02-25 | 2016-01-19 | Femasys Inc. | Methods and devices for delivering to conduit |
US7736671B2 (en) | 2004-03-02 | 2010-06-15 | Boston Scientific Scimed, Inc. | Embolization |
US8067073B2 (en) * | 2004-03-25 | 2011-11-29 | Boston Scientific Scimed, Inc. | Thermoplastic medical device |
US8173176B2 (en) | 2004-03-30 | 2012-05-08 | Boston Scientific Scimed, Inc. | Embolization |
JP4655505B2 (en) * | 2004-04-28 | 2011-03-23 | 東レ株式会社 | Crosslinked biodegradable particles and method for producing the same |
CA2565721C (en) * | 2004-05-06 | 2015-10-06 | Bioresponse, L.L.C. | Diindolymethane formulations for the treatment of leiomyomas |
US20050266043A1 (en) * | 2004-05-27 | 2005-12-01 | Medtronic Vascular, Inc. | Methods and compounds for treatment of aneurysmal tissue |
US7311861B2 (en) | 2004-06-01 | 2007-12-25 | Boston Scientific Scimed, Inc. | Embolization |
US7666225B2 (en) * | 2004-06-29 | 2010-02-23 | Hassan Chaouk | Spinal disc nucleus pulposus implant |
US20070281028A1 (en) * | 2004-08-04 | 2007-12-06 | Biocompatibles Uk Limited | Drug Delivery of a Cox Inhibitor from Embolic Agents |
US20060045900A1 (en) * | 2004-08-27 | 2006-03-02 | Robert Richard | Embolization |
US9107850B2 (en) * | 2004-10-25 | 2015-08-18 | Celonova Biosciences, Inc. | Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
US9114162B2 (en) | 2004-10-25 | 2015-08-25 | Celonova Biosciences, Inc. | Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same |
US20210299056A9 (en) | 2004-10-25 | 2021-09-30 | Varian Medical Systems, Inc. | Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods |
ATE503465T1 (en) | 2004-10-25 | 2011-04-15 | Celonova Biosciences Germany Gmbh | LOADABLE POLYPHOSPHAZENE-CONTAINING PARTICLES FOR THERAPEUTIC AND/OR DIAGNOSTIC APPLICATIONS AND PRODUCTION AND USE METHODS THEREOF |
US7780645B2 (en) * | 2004-10-26 | 2010-08-24 | Codman & Shurtleff, Inc. | Method of delivering embolic particles to an aneurysm |
US8425550B2 (en) | 2004-12-01 | 2013-04-23 | Boston Scientific Scimed, Inc. | Embolic coils |
WO2006062871A2 (en) * | 2004-12-08 | 2006-06-15 | Pervasis Therapeutics, Inc. | Materials and methods for minimally-invasive administration of a cell-containing flowable composition |
CA2881343A1 (en) * | 2004-12-08 | 2006-06-15 | Shire Regenerative Medicine, Inc. | Methods and compositions for enhancing vascular access |
WO2006083458A2 (en) | 2004-12-30 | 2006-08-10 | Bioresponse Llc | Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associates conditions |
WO2006078841A1 (en) * | 2005-01-21 | 2006-07-27 | President And Fellows Of Harvard College | Systems and methods for forming fluidic droplets encapsulated in particles such as colloidal particles |
US20060178696A1 (en) * | 2005-02-04 | 2006-08-10 | Porter Stephen C | Macroporous materials for use in aneurysms |
WO2006086442A2 (en) * | 2005-02-08 | 2006-08-17 | Case Western Reserve University | Method of detecting abnormal tissue |
US7858183B2 (en) | 2005-03-02 | 2010-12-28 | Boston Scientific Scimed, Inc. | Particles |
US7727555B2 (en) | 2005-03-02 | 2010-06-01 | Boston Scientific Scimed, Inc. | Particles |
JP5174656B2 (en) * | 2005-04-21 | 2013-04-03 | マサチューセッツ インスティテュート オブ テクノロジー | Materials and methods for modifying an immune response against exogenous and endogenous immunogens, including syngeneic or non-syngeneic cells, tissues or organs |
US7963287B2 (en) | 2005-04-28 | 2011-06-21 | Boston Scientific Scimed, Inc. | Tissue-treatment methods |
CA2818182C (en) | 2005-06-21 | 2015-04-14 | Shire Regenerative Medicine, Inc. | Methods and compositions for enhancing vascular access |
US9463426B2 (en) | 2005-06-24 | 2016-10-11 | Boston Scientific Scimed, Inc. | Methods and systems for coating particles |
WO2007004484A1 (en) * | 2005-07-01 | 2007-01-11 | The Nippon Synthetic Chemical Industry Co., Ltd. | Pva particle for use in temporary embolization of blood vessel, process for production thereof, and temporary embolizing agent for blood vessel |
JP5292533B2 (en) * | 2005-08-26 | 2013-09-18 | ジンマー・インコーポレイテッド | Implant and joint disease treatment, replacement and treatment methods |
US20070078480A1 (en) * | 2005-10-04 | 2007-04-05 | Boston Scientific Scimed, Inc. | Self-expanding biodegradable or water-soluble vaso-occlusive devices |
US8007509B2 (en) | 2005-10-12 | 2011-08-30 | Boston Scientific Scimed, Inc. | Coil assemblies, components and methods |
US20070093907A1 (en) * | 2005-10-26 | 2007-04-26 | Goupil Dennis W | Hydrogel spinal disc implants with swellable articles |
US20100204783A1 (en) * | 2005-12-06 | 2010-08-12 | Helen Marie Nugent | Methods and compositions for enhancing vascular access |
US8152839B2 (en) | 2005-12-19 | 2012-04-10 | Boston Scientific Scimed, Inc. | Embolic coils |
US8101197B2 (en) | 2005-12-19 | 2012-01-24 | Stryker Corporation | Forming coils |
US7947368B2 (en) | 2005-12-21 | 2011-05-24 | Boston Scientific Scimed, Inc. | Block copolymer particles |
US20070149641A1 (en) * | 2005-12-28 | 2007-06-28 | Goupil Dennis W | Injectable bone cement |
EP2368581B1 (en) * | 2006-01-30 | 2018-08-29 | Biosphere Medical, Inc. | Porous intravascular embolization particles and related methods |
US20070244544A1 (en) * | 2006-04-14 | 2007-10-18 | Medtronic Vascular, Inc. | Seal for Enhanced Stented Valve Fixation |
US8242179B2 (en) * | 2006-06-23 | 2012-08-14 | Surmodics, Inc. | Hydrogel-based joint repair system and method |
WO2008057253A2 (en) * | 2006-10-27 | 2008-05-15 | Bioresponse, L.L.C. | Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles |
US8414927B2 (en) | 2006-11-03 | 2013-04-09 | Boston Scientific Scimed, Inc. | Cross-linked polymer particles |
US20100092532A1 (en) * | 2006-11-07 | 2010-04-15 | Helen Marie Nugent | Materials and Methods for Treating and Managing Angiogenesis-Mediated Diseases |
US20080154233A1 (en) * | 2006-12-20 | 2008-06-26 | Zimmer Orthobiologics, Inc. | Apparatus for delivering a biocompatible material to a surgical site and method of using same |
US8163549B2 (en) | 2006-12-20 | 2012-04-24 | Zimmer Orthobiologics, Inc. | Method of obtaining viable small tissue particles and use for tissue repair |
US7720533B2 (en) * | 2006-12-20 | 2010-05-18 | Zimmer Orthobiologicals, Inc. | Apparatus and method for delivering a biocompatible material to a surgical site |
WO2008128075A1 (en) * | 2007-04-12 | 2008-10-23 | Isto Technologies, Inc. | Compositions and methods for tissue repair |
US20080255678A1 (en) * | 2007-04-13 | 2008-10-16 | Cully Edward H | Medical apparatus and method of making the same |
US9642693B2 (en) * | 2007-04-13 | 2017-05-09 | W. L. Gore & Associates, Inc. | Medical apparatus and method of making the same |
US9717584B2 (en) * | 2007-04-13 | 2017-08-01 | W. L. Gore & Associates, Inc. | Medical apparatus and method of making the same |
US20080287633A1 (en) * | 2007-05-18 | 2008-11-20 | Drumheller Paul D | Hydrogel Materials |
US20100185156A1 (en) * | 2007-06-13 | 2010-07-22 | Pervasis Therapeutics, Inc. | Methods and Devices for Minimally-Invasive Delivery of Cell-Containing Flowable Compositions |
EP2162101B1 (en) | 2007-06-25 | 2019-02-20 | MicroVention, Inc. | Self-expanding prosthesis |
US8480651B2 (en) * | 2007-08-02 | 2013-07-09 | Covidien Lp | Cannula system |
US7887846B2 (en) * | 2007-08-07 | 2011-02-15 | E. I. Du Pont De Nemours And Company | Process for preparation of swellable and degradable microspheres |
JP5179308B2 (en) * | 2007-10-03 | 2013-04-10 | 株式会社クラレ | Polyvinyl acetal |
US20090111763A1 (en) * | 2007-10-26 | 2009-04-30 | Celonova Biosciences, Inc. | Loadable polymeric particles for bone augmentation and methods of preparing and using the same |
US20090110738A1 (en) * | 2007-10-26 | 2009-04-30 | Celonova Biosciences, Inc. | Loadable Polymeric Particles for Cosmetic and Reconstructive Tissue Augmentation Applications and Methods of Preparing and Using the Same |
US20090110730A1 (en) * | 2007-10-30 | 2009-04-30 | Celonova Biosciences, Inc. | Loadable Polymeric Particles for Marking or Masking Individuals and Methods of Preparing and Using the Same |
US20090110731A1 (en) * | 2007-10-30 | 2009-04-30 | Celonova Biosciences, Inc. | Loadable Polymeric Microparticles for Therapeutic Use in Alopecia and Methods of Preparing and Using the Same |
US20090123519A1 (en) * | 2007-11-12 | 2009-05-14 | Surmodics, Inc. | Swellable hydrogel matrix and methods |
EP2254652A4 (en) * | 2008-02-29 | 2017-05-03 | Genzyme Corporation | Local embolization via heating of thermosensitive polymers |
JP5836592B2 (en) * | 2008-02-29 | 2015-12-24 | プルーロームド インコーポレイテッドPluromed, Inc. | Local embolization using thermosensitive polymers |
US20090226531A1 (en) * | 2008-03-07 | 2009-09-10 | Allergan, Inc. | Methods and composition for intraocular delivery of therapeutic sirna |
US8114436B2 (en) * | 2008-03-25 | 2012-02-14 | Boston Scientific Scimed, Inc. | Compositions and methods for delivery of embolics |
US20100076463A1 (en) * | 2008-04-04 | 2010-03-25 | Akshay Mavani | Implantable fistula closure device |
US8246876B2 (en) * | 2008-08-18 | 2012-08-21 | Cook Medical Technologies Llc | Embolization particles and method for making same |
EP2330985A4 (en) | 2008-09-04 | 2015-11-18 | Curaseal Inc | Inflatable devices for enteric fistula treatment |
US9554826B2 (en) | 2008-10-03 | 2017-01-31 | Femasys, Inc. | Contrast agent injection system for sonographic imaging |
US10070888B2 (en) | 2008-10-03 | 2018-09-11 | Femasys, Inc. | Methods and devices for sonographic imaging |
WO2010048177A2 (en) * | 2008-10-20 | 2010-04-29 | IMDS, Inc. | Systems and methods for aneurysm treatment and vessel occlusion |
EP2344578A2 (en) * | 2008-10-30 | 2011-07-20 | David Liu | Micro-spherical porous biocompatible scaffolds and methods and apparatus for fabricating same |
US20120123355A1 (en) * | 2009-07-30 | 2012-05-17 | Cook Medical Technologied | Erodible embolization material |
US20110065809A1 (en) * | 2009-09-15 | 2011-03-17 | Medtronic, Inc. | Polymerization of Multifunctional Azides, and Polymers Therefrom |
US8795727B2 (en) | 2009-11-09 | 2014-08-05 | Spotlight Technology Partners Llc | Fragmented hydrogels |
US9700650B2 (en) | 2009-11-09 | 2017-07-11 | Spotlight Technology Partners Llc | Polysaccharide based hydrogels |
EP2523700B1 (en) * | 2010-01-13 | 2018-03-07 | Georg Bischof | Composition for producing a temporary intestinal occlusion |
US7955301B1 (en) | 2010-01-27 | 2011-06-07 | Warsaw Orthopedic, Inc. | Injection shut off valve with pressure actuator for delivery of compositions |
US9050274B2 (en) * | 2010-01-28 | 2015-06-09 | Warsaw Orthopedic, Inc. | Compositions and methods for treating an intervertebral disc using bulking agents or sealing agents |
US9125902B2 (en) * | 2010-01-28 | 2015-09-08 | Warsaw Orthopedic, Inc. | Methods for treating an intervertebral disc using local analgesics |
US9486500B2 (en) | 2010-01-28 | 2016-11-08 | Warsaw Orthopedic, Inc. | Osteoimplant and methods for making |
US9232805B2 (en) | 2010-06-29 | 2016-01-12 | Biocure, Inc. | In-situ forming hydrogel wound dressings containing antimicrobial agents |
US9511077B2 (en) | 2011-04-25 | 2016-12-06 | Warsaw Orthopedic, Inc. | Medical devices and methods comprising an anabolic agent for wound healing |
US9592243B2 (en) | 2011-04-25 | 2017-03-14 | Warsaw Orthopedic, Inc. | Medical devices and methods comprising an anabolic agent for treatment of an injury |
CN103874466B (en) | 2011-06-16 | 2016-10-05 | 库拉希尔公司 | Device and correlation technique for fistula treatment |
WO2012174468A1 (en) | 2011-06-17 | 2012-12-20 | Curaseal Inc. | Fistula treatment devices and methods |
US10137280B2 (en) * | 2011-06-30 | 2018-11-27 | Incube Labs, Llc | System and method for treatment of hemorrhagic stroke |
AT511671A1 (en) * | 2011-07-13 | 2013-01-15 | Bischof Georg Dr | COMPOSITION FOR GENERATING TEMPORARY OCCLUSION OF THE IMMUNE OF AN IMAGE AGENT |
WO2013151991A1 (en) | 2012-04-02 | 2013-10-10 | Surmodics, Inc. | Hydrophilic polymeric coatings for medical articles with visualization moiety |
EP3984556A1 (en) | 2012-06-14 | 2022-04-20 | Microvention, Inc. | Polymeric treatment compositions |
CN104717983B (en) | 2012-10-15 | 2018-09-18 | 微仙美国有限公司 | It polymerize therapeutic combination |
US20140178343A1 (en) | 2012-12-21 | 2014-06-26 | Jian Q. Yao | Supports and methods for promoting integration of cartilage tissue explants |
JP6420817B2 (en) * | 2013-03-15 | 2018-11-07 | バイオコンパティブルズ ユーケー リミテッド | Imageable embolic microspheres |
WO2015042170A1 (en) | 2013-09-17 | 2015-03-26 | Wayne State University | Compositions and uses of combinations of dim-related indoles and selected anti-androgen compounds |
FR3017295B1 (en) * | 2014-02-07 | 2018-01-12 | Guerbet | COMPOSITION FOR VECTORIZING AN ANTICANCER AGENT |
CN106659874B (en) | 2014-03-26 | 2021-01-05 | 文科罗斯公司 | Treatment of venous diseases |
US9775978B2 (en) | 2014-07-25 | 2017-10-03 | Warsaw Orthopedic, Inc. | Drug delivery device and methods having a retaining member |
US9764122B2 (en) | 2014-07-25 | 2017-09-19 | Warsaw Orthopedic, Inc. | Drug delivery device and methods having an occluding member |
JP7055021B2 (en) | 2015-03-02 | 2022-04-15 | アキュレイト メディカル セラピューティクス リミテッド | Catheter with side openings to modify and deliver suspension to the patient |
EP4299019A3 (en) * | 2015-04-01 | 2024-03-06 | Boston Scientific Scimed, Inc. | Systems for delivery of gel embolics |
US10071181B1 (en) | 2015-04-17 | 2018-09-11 | Teleflex Innovations S.À.R.L. | Resorbable embolization spheres |
MX370083B (en) | 2015-05-06 | 2019-11-29 | Zoetis Services Llc | Hydrogel formulation with mild adhesion. |
FR3039767B1 (en) | 2015-08-04 | 2017-09-08 | Guerbet Sa | COMPOSITION FOR VECTORIZING AN ANTICANCER AGENT |
US10076650B2 (en) | 2015-11-23 | 2018-09-18 | Warsaw Orthopedic, Inc. | Enhanced stylet for drug depot injector |
US10549081B2 (en) | 2016-06-23 | 2020-02-04 | Warsaw Orthopedic, Inc. | Drug delivery device and methods having a retaining member |
US10368874B2 (en) | 2016-08-26 | 2019-08-06 | Microvention, Inc. | Embolic compositions |
US10434261B2 (en) | 2016-11-08 | 2019-10-08 | Warsaw Orthopedic, Inc. | Drug pellet delivery system and method |
KR20200036815A (en) | 2017-05-26 | 2020-04-07 | 브루인 바이오사이언시스, 인크. | Chemical embolizer |
CN111200976B (en) | 2017-10-09 | 2023-07-07 | 微仙美国有限公司 | Radioactive liquid embolism |
US11590080B2 (en) | 2017-12-18 | 2023-02-28 | C.R. Bard, Inc. | Drug-loaded biodegradable microbead compositions including drug-containing vesicular agents |
WO2019222482A1 (en) | 2018-05-16 | 2019-11-21 | Spirox, Inc. | Allergic rhinitis drug delivery implant |
GB201810784D0 (en) * | 2018-06-29 | 2018-08-15 | Biocompatibles Uk Ltd | Radiopaque polymers |
CA3120558A1 (en) * | 2018-11-21 | 2020-05-28 | Kuraray Co., Ltd. | Monodisperse hydrogel particles |
US20210022743A1 (en) * | 2019-07-22 | 2021-01-28 | Boston Scientific Scimed, Inc. | In vivo crosslinking of embolic hydrogels using bioorthogonal click chemistry |
CN115379866A (en) * | 2020-03-31 | 2022-11-22 | 泰尔茂株式会社 | Embolism agent |
WO2022010850A1 (en) * | 2020-07-06 | 2022-01-13 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Polymeric carriers for delivery of therapeutic agents |
WO2022051530A1 (en) * | 2020-09-04 | 2022-03-10 | Blackswan Vascular, Inc. | Liquid embolic compositions with controlled release of radiopaque and therapeutic compounds and methods of using the same |
US20230037198A1 (en) * | 2021-07-29 | 2023-02-02 | Varian Medical Systems, Inc. | Apparatuses and methods for producing embolic particles with activated loading sites |
CN113797383A (en) * | 2021-09-28 | 2021-12-17 | 迪格瑞医疗科技(苏州)有限公司 | High-elasticity high-drug-loading-rate embolism microsphere and preparation method thereof |
CN116115818A (en) * | 2021-11-12 | 2023-05-16 | 刘庄 | Active metal microsphere, composite embolic agent based on active metal microsphere and application of composite embolic agent |
CN115501378B (en) * | 2022-09-23 | 2023-08-22 | 江南大学 | Modified polyvinyl alcohol embolism microsphere and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5508317A (en) * | 1993-08-06 | 1996-04-16 | Ciba-Geigy Corporation | Photocrosslinked polymers |
WO1999012577A1 (en) * | 1997-09-05 | 1999-03-18 | Nycomed Imaging As | Polymer particles made of polyvinyl alcohol and comprising a contrast agent for chemoembolization |
WO2001044307A2 (en) * | 1999-11-15 | 2001-06-21 | Biocure, Inc. | Degradable poly(vinyl alcohol) hydrogels |
Family Cites Families (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1566330A (en) * | 1977-02-16 | 1980-04-30 | Farmaceutici Italia | Anthracycline glycosides |
JPS6317904A (en) | 1986-07-09 | 1988-01-25 | Mitsubishi Chem Ind Ltd | Production of crosslinked porous polyvinyl alcohol particle |
JPS63242272A (en) * | 1987-03-31 | 1988-10-07 | テルモ株式会社 | Composition for expanding balloon of balloon catheter |
US5843156A (en) | 1988-08-24 | 1998-12-01 | Endoluminal Therapeutics, Inc. | Local polymeric gel cellular therapy |
US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
DE3841401A1 (en) | 1988-12-08 | 1990-06-13 | Martin Lemperle | ALLOPLASTIC IMPLANT |
US5202352A (en) | 1990-08-08 | 1993-04-13 | Takeda Chemical Industries, Ltd. | Intravascular embolizing agent containing angiogenesis-inhibiting substance |
US5529914A (en) * | 1990-10-15 | 1996-06-25 | The Board Of Regents The Univeristy Of Texas System | Gels for encapsulation of biological materials |
US5410016A (en) | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
US5047055A (en) | 1990-12-21 | 1991-09-10 | Pfizer Hospital Products Group, Inc. | Hydrogel intervertebral disc nucleus |
JP2576292B2 (en) * | 1991-01-29 | 1997-01-29 | 株式会社日立製作所 | Condenser and power plant using the same |
FR2676927B1 (en) | 1991-05-29 | 1995-06-23 | Ibf | MICROSPHERES FOR USE IN THERAPEUTIC VASCULAR OCCLUSIONS AND INJECTABLE SOLUTIONS CONTAINING THEM. |
US5514379A (en) | 1992-08-07 | 1996-05-07 | The General Hospital Corporation | Hydrogel compositions and methods of use |
US5800373A (en) | 1995-03-23 | 1998-09-01 | Focal, Inc. | Initiator priming for improved adherence of gels to substrates |
US5709854A (en) | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
US5394727A (en) * | 1993-08-18 | 1995-03-07 | Aluminum Company Of America | Method of forming a metal container body |
WO1996011671A1 (en) | 1994-10-12 | 1996-04-25 | Focal, Inc. | Targeted delivery via biodegradable polymers |
AU4438696A (en) | 1995-02-03 | 1996-08-21 | Novartis Ag | Crosslinked polymers |
DE69521025T2 (en) | 1995-03-07 | 2001-10-04 | Menlo Care Inc | Means to improve sphincter function with controlled expansion |
US6129761A (en) | 1995-06-07 | 2000-10-10 | Reprogenesis, Inc. | Injectable hydrogel compositions |
US5580568A (en) | 1995-07-27 | 1996-12-03 | Micro Therapeutics, Inc. | Cellulose diacetate compositions for use in embolizing blood vessels |
DE69626992T2 (en) | 1995-07-27 | 2003-12-18 | Micro Therapeutics Inc | NEW EMBOLIZING COMPOSITIONS |
US5667767A (en) | 1995-07-27 | 1997-09-16 | Micro Therapeutics, Inc. | Compositions for use in embolizing blood vessels |
WO1997005185A2 (en) | 1995-07-28 | 1997-02-13 | Focal, Inc. | Multiblock biodegradable hydrogels for use as controlled release agents for drugs delivery and tissue treatment agents |
US5833652A (en) | 1995-09-18 | 1998-11-10 | Y. Pierre Gobin | Component mixing catheter |
EP1704878B1 (en) | 1995-12-18 | 2013-04-10 | AngioDevice International GmbH | Crosslinked polymer compositions and methods for their use |
US5752974A (en) | 1995-12-18 | 1998-05-19 | Collagen Corporation | Injectable or implantable biomaterials for filling or blocking lumens and voids of the body |
US5702361A (en) * | 1996-01-31 | 1997-12-30 | Micro Therapeutics, Inc. | Method for embolizing blood vessels |
US5902599A (en) | 1996-02-20 | 1999-05-11 | Massachusetts Institute Of Technology | Biodegradable polymer networks for use in orthopedic and dental applications |
CA2248076A1 (en) | 1996-03-11 | 1997-09-18 | Richard D. Leavitt | Polymeric delivery of radionuclides and radiopharmaceuticals |
US6060534A (en) | 1996-07-11 | 2000-05-09 | Scimed Life Systems, Inc. | Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties |
JP4717164B2 (en) | 1996-07-29 | 2011-07-06 | マイクロ・セラピューティクス・インコーポレーテッド | A novel method for embolizing luminal sites with embolic compositions containing dimethyl sulfoxide |
US5823198A (en) | 1996-07-31 | 1998-10-20 | Micro Therapeutics, Inc. | Method and apparatus for intravasculer embolization |
AR008108A1 (en) * | 1996-08-01 | 1999-12-09 | Novartis Ag | A METHOD FOR FORMING A RADIATION ABSORBENT POLYMERIC ARTICLE, A POLYMERIC ARTICLE SO FORMED, AND A METHOD FOR FORMING A POLYMERIC DYE |
ZA978537B (en) | 1996-09-23 | 1998-05-12 | Focal Inc | Polymerizable biodegradable polymers including carbonate or dioxanone linkages. |
US5925683A (en) | 1996-10-17 | 1999-07-20 | Target Therapeutics, Inc. | Liquid embolic agents |
US5785642A (en) | 1996-10-18 | 1998-07-28 | Micro Therapeutics, Inc. | Methods for treating urinary incontinence in mammals |
WO1998017200A1 (en) | 1996-10-18 | 1998-04-30 | Micro Therapeutics, Inc. | Method for treating urinary reflux |
US5981826A (en) | 1997-05-05 | 1999-11-09 | Georgia Tech Research Corporation | Poly(vinyl alcohol) cryogel |
BR9811793A (en) | 1997-07-18 | 2000-09-26 | Infimed Inc | Biodegradable macromers for the controlled release of biologically active substances. |
US6265509B1 (en) * | 1997-07-30 | 2001-07-24 | Novartis Ag | Crosslinked polymers |
US5854382A (en) | 1997-08-18 | 1998-12-29 | Meadox Medicals, Inc. | Bioresorbable compositions for implantable prostheses |
US6037366A (en) | 1997-09-11 | 2000-03-14 | Prohold Medical Technologies, Inc. | Composition for creating vascular occlusions |
AU742786B2 (en) | 1998-03-06 | 2002-01-10 | Biosphere Medical, Inc. | Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
US6660301B1 (en) | 1998-03-06 | 2003-12-09 | Biosphere Medical, Inc. | Injectable microspheres for dermal augmentation and tissue bulking |
US6152943A (en) | 1998-08-14 | 2000-11-28 | Incept Llc | Methods and apparatus for intraluminal deposition of hydrogels |
US6514534B1 (en) | 1998-08-14 | 2003-02-04 | Incept Llc | Methods for forming regional tissue adherent barriers and drug delivery systems |
US6818018B1 (en) * | 1998-08-14 | 2004-11-16 | Incept Llc | In situ polymerizable hydrogels |
DE69943297D1 (en) | 1998-08-14 | 2011-05-05 | Incept Llc | APPARATUS FOR IN-SITU-EDUCATION OF HYDROGELS |
US6632457B1 (en) | 1998-08-14 | 2003-10-14 | Incept Llc | Composite hydrogel drug delivery systems |
FR2784580B1 (en) | 1998-10-16 | 2004-06-25 | Biosepra Inc | POLYVINYL-ALCOHOL MICROSPHERES AND METHODS OF MAKING THE SAME |
US6231613B1 (en) | 1998-12-15 | 2001-05-15 | Enteric Medical Technologies, Inc. | Methods for soft tissue augmentation in mammals |
EP1148895B1 (en) | 1999-02-05 | 2004-11-17 | The Regents of the University of California | Thermo-reversible polymer for intralumenal implant |
WO2000050103A1 (en) | 1999-02-25 | 2000-08-31 | Scimed Life Systems, Inc. | Medical devices comprising hydrogel polymers having improved mechanical properties |
US6203779B1 (en) | 1999-03-19 | 2001-03-20 | Charlie Ricci | Methods for treating endoleaks during endovascular repair of abdominal aortic aneurysms |
US6303100B1 (en) | 1999-03-19 | 2001-10-16 | Micro Therapeutics, Inc. | Methods for inhibiting the formation of potential endoleaks associated with endovascular repair of abdominal aortic aneurysms |
US6312725B1 (en) | 1999-04-16 | 2001-11-06 | Cohesion Technologies, Inc. | Rapid gelling biocompatible polymer composition |
WO2000064977A1 (en) | 1999-04-26 | 2000-11-02 | California Institute Of Technology | In situ forming hydrogels |
EP2093245B1 (en) | 1999-08-27 | 2012-02-22 | AngioDevice International GmbH | Biocompatible polymer device |
IL148532A0 (en) | 1999-09-10 | 2002-09-12 | Focal Inc | Hydrogels for orthopedic repair |
KR100335866B1 (en) | 2000-01-06 | 2002-05-10 | 박호군 | Microspheric Embolic Materials Having Duel Structure of Poly(Vinyl Acetate) Core/Poly(Vinyl Alcohol) Shell, and Method for Preparing The Same |
US6699504B2 (en) | 2000-01-28 | 2004-03-02 | Pelias Technologies, Inc. | Slow release protein polymers |
JP4871476B2 (en) | 2000-03-13 | 2012-02-08 | バイオコンパティブルズ ユーケー リミテッド | Embolization composition |
WO2001070290A2 (en) | 2000-03-20 | 2001-09-27 | Biosphere Medical, Inc. | Injectable microspheres for tissue construction |
EP1274472A2 (en) | 2000-03-20 | 2003-01-15 | Biosphere Medical, Inc. | Injectable and swellable microspheres for tissue bulking |
US6436424B1 (en) | 2000-03-20 | 2002-08-20 | Biosphere Medical, Inc. | Injectable and swellable microspheres for dermal augmentation |
WO2001072281A2 (en) | 2000-03-24 | 2001-10-04 | Biosphere Medical Inc. | Microspheres for active embolization |
CA2425212A1 (en) | 2000-08-23 | 2002-02-28 | Phairson Medical, Inc. | Novel polymer compounds |
-
2001
- 2001-03-13 JP JP2001567808A patent/JP4871476B2/en not_active Expired - Lifetime
- 2001-03-13 US US09/804,963 patent/US6676971B2/en not_active Expired - Lifetime
- 2001-03-13 EP EP01918602A patent/EP1263803B1/en not_active Expired - Lifetime
- 2001-03-13 WO PCT/US2001/007940 patent/WO2001068720A1/en active IP Right Grant
- 2001-03-13 AU AU2001245660A patent/AU2001245660B2/en not_active Expired
- 2001-03-13 CA CA2403218A patent/CA2403218C/en not_active Expired - Lifetime
- 2001-03-13 AU AU4566001A patent/AU4566001A/en active Pending
- 2001-03-13 AT AT01918602T patent/ATE373682T1/en not_active IP Right Cessation
- 2001-03-13 DE DE60130544T patent/DE60130544T2/en not_active Expired - Lifetime
-
2003
- 2003-06-19 US US10/465,497 patent/US20030223956A1/en not_active Abandoned
-
2009
- 2009-04-23 US US12/386,828 patent/US8221735B2/en not_active Ceased
-
2014
- 2014-07-17 US US14/334,294 patent/USRE47121E1/en not_active Expired - Lifetime
-
2015
- 2015-03-16 US US14/659,377 patent/USRE47873E1/en not_active Expired - Lifetime
-
2018
- 2018-07-26 US US16/045,954 patent/USRE48302E1/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5508317A (en) * | 1993-08-06 | 1996-04-16 | Ciba-Geigy Corporation | Photocrosslinked polymers |
WO1999012577A1 (en) * | 1997-09-05 | 1999-03-18 | Nycomed Imaging As | Polymer particles made of polyvinyl alcohol and comprising a contrast agent for chemoembolization |
WO2001044307A2 (en) * | 1999-11-15 | 2001-06-21 | Biocure, Inc. | Degradable poly(vinyl alcohol) hydrogels |
Cited By (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10265271B2 (en) | 2000-03-24 | 2019-04-23 | Biosphere Medical, Inc. | Microspheres for the treatment of a prostate hyperplasia by active embolization |
WO2002009789A3 (en) * | 2000-08-02 | 2002-04-18 | Aesculap Ag & Co Kg | Medical technical product, method for producing the same and providing the same for surgery |
JP2004504887A (en) * | 2000-08-02 | 2004-02-19 | アエスクラップ アーゲー ウント コー カーゲー | Medical technology products, their production methods and their surgical uses |
WO2002009789A2 (en) * | 2000-08-02 | 2002-02-07 | Aesculap Ag & Co. Kg | Medical technical product, method for producing the same and providing the same for surgery |
WO2002072166A1 (en) * | 2001-03-13 | 2002-09-19 | Biocure, Inc. | Compositions for drug delivery |
EP1460982A1 (en) * | 2001-11-16 | 2004-09-29 | BioCure, Inc. | Methods for initiating in situ formation of hydrogels |
EP1460982A4 (en) * | 2001-11-16 | 2010-04-14 | Biocure Inc | Methods for initiating in situ formation of hydrogels |
US7207996B2 (en) | 2002-04-04 | 2007-04-24 | Vascular Control Systems, Inc. | Doppler directed suturing and compression device and method |
US6713646B2 (en) | 2002-04-12 | 2004-03-30 | Biosphere Medical | Degradable crosslinkers, and degradable crosslinked hydrogels comprising them |
US7135593B2 (en) | 2002-04-12 | 2006-11-14 | Biosphere Medical, Inc. | Degradable crosslinkers, and degradable crosslinked hydrogels comprising them |
US6884905B2 (en) | 2002-07-23 | 2005-04-26 | Biosphere Medical | Degradable carbamate-containing bis(acryloyl) crosslinkers, and degradable crosslinked hydrogels comprising them |
WO2004028569A1 (en) * | 2002-09-25 | 2004-04-08 | Biocompatibles Uk Limited | Polymer compositions for administration to animals |
JP4895802B2 (en) * | 2003-02-12 | 2012-03-14 | バイオコンパティブルズ ユーケー リミテッド | Composition for chemoembolization of solid tumors |
WO2004071495A1 (en) * | 2003-02-12 | 2004-08-26 | Biocompatibles Uk Limited | Composition for chemoembolotherapy of solid tumors |
CN106344968A (en) * | 2003-02-12 | 2017-01-25 | 生物相容英国有限公司 | Use of composition in manufacture of medicament for formation of embolism in circulatory system of patients with solid tumors during in embolotherapy |
CN103908704A (en) * | 2003-02-12 | 2014-07-09 | 生物相容英国有限公司 | Composition For Chemoembolotherapy Of Solid Tumors |
US9901590B2 (en) | 2003-02-12 | 2018-02-27 | Biocompatibles Uk Limited | Chemoembolisation |
CN103393605A (en) * | 2003-02-12 | 2013-11-20 | 生物相容英国有限公司 | Composition for chemoembolotherapy of solid tumors |
US8455003B2 (en) | 2003-02-12 | 2013-06-04 | Biocompatibles Uk Limited | Chemoembolisation |
US9241895B2 (en) | 2003-02-12 | 2016-01-26 | Biocompatibles Uk Limited | Chemoembolisation |
JP2006515358A (en) * | 2003-02-12 | 2006-05-25 | バイオコンパティブルズ ユーケー リミテッド | Composition for chemoembolization of solid tumors |
CN106267325A (en) * | 2003-02-12 | 2017-01-04 | 生物相容英国有限公司 | A kind of production method of compositions |
US8221793B2 (en) | 2003-02-12 | 2012-07-17 | Biocompatibles Uk Limited | Chemoembolisation |
CN103393605B (en) * | 2003-02-12 | 2018-05-29 | 生物相容英国有限公司 | For the composition of the chemoembolization of solid tumor |
JP2011178784A (en) * | 2003-02-12 | 2011-09-15 | Biocompatibles Uk Ltd | Composition for chemoembolotherapy of solid tumor |
CN106267325B (en) * | 2003-02-12 | 2019-09-24 | 生物相容英国有限公司 | A kind of production method of composition |
US7442385B2 (en) * | 2003-02-12 | 2008-10-28 | Biocompatibles Uk Limited | Chemoembolisation |
WO2004073688A1 (en) * | 2003-02-21 | 2004-09-02 | Biocompatibles Uk Limited | Drug delivery from embolic agents |
JP2014039882A (en) * | 2003-03-24 | 2014-03-06 | Pluromed Inc | Temporary embolization using inverse thermosensitive polymers |
WO2004087007A3 (en) * | 2003-03-25 | 2005-07-07 | Biocure Inc | Hydrogel string medical device |
WO2004087007A2 (en) * | 2003-03-25 | 2004-10-14 | Biocure, Inc. | Hydrogel string medical device |
WO2004091683A2 (en) * | 2003-04-11 | 2004-10-28 | Vascular Control Systems, Inc. | Embolic occlusion of uterine arteries |
WO2004091683A3 (en) * | 2003-04-11 | 2005-05-06 | Vascular Control Systems Inc | Embolic occlusion of uterine arteries |
WO2004096869A1 (en) * | 2003-04-29 | 2004-11-11 | Basf Corporation | Method for creating microsphere polymers and particles |
US7022747B2 (en) | 2003-04-29 | 2006-04-04 | Basf Corporation | Method for creating microsphere polymers and particles |
WO2005087193A3 (en) * | 2004-03-11 | 2006-06-08 | Biocompatibles Uk Ltd | Chemoembolisation involving an anthracycline compound |
WO2005087193A2 (en) * | 2004-03-11 | 2005-09-22 | Biocompatibles Uk Limited | Chemoembolisation involving an anthracycline compound |
DE102004014633A1 (en) * | 2004-03-22 | 2005-10-13 | Aesculap Ag & Co. Kg | Composition for adhesion prophylaxis |
WO2006013309A1 (en) * | 2004-08-03 | 2006-02-09 | Biocompatibles Uk Limited | Drug delivery from embolic agents |
WO2006026412A3 (en) * | 2004-08-31 | 2006-07-13 | Vnus Med Tech Inc | Apparatus and material composition for permanent occlusion of a hollow anatomical structure |
WO2006026412A2 (en) * | 2004-08-31 | 2006-03-09 | Vnus Medical Technologies, Inc. | Apparatus and material composition for permanent occlusion of a hollow anatomical structure |
EP1824414A2 (en) * | 2004-11-16 | 2007-08-29 | MicroVention, Inc. | Compositions, systems and methods for treatment of defects in blood vessels |
EP1824414A4 (en) * | 2004-11-16 | 2012-06-27 | Microvention Inc | Compositions, systems and methods for treatment of defects in blood vessels |
US8968353B2 (en) | 2005-01-25 | 2015-03-03 | Covidien Lp | Method and apparatus for impeding migration of an implanted occlusive structure |
US9017350B2 (en) | 2005-01-25 | 2015-04-28 | Covidien Lp | Expandable occlusive structure |
US9040022B2 (en) | 2005-05-09 | 2015-05-26 | Biosphere Medical, S.A. | Compositions and methods using microspheres and non-ionic contrast agents |
EP3085362A1 (en) * | 2005-05-09 | 2016-10-26 | Biosphere Medical, S.A. | Compositions and methods using microspheres and non-ionic contrast agents |
US10293063B2 (en) | 2005-05-09 | 2019-05-21 | Merit Medical Systems, Inc. | Compositions and methods using microspheres and non-ionic contrast agents |
EP2484344A3 (en) * | 2005-05-09 | 2012-09-12 | Biosphere Medical, S.A. | Compositions and methods of using microspheres and non-ionic contrast agents |
WO2007085615A1 (en) * | 2006-01-24 | 2007-08-02 | Biocompatibles Uk Limited | Process for loading polymer particles with drug |
US10448955B2 (en) | 2006-01-30 | 2019-10-22 | Biosphere Medical, Inc. | Compressible intravascular embolization particles and related methods and delivery systems |
US9017361B2 (en) | 2006-04-20 | 2015-04-28 | Covidien Lp | Occlusive implant and methods for hollow anatomical structure |
WO2007142916A2 (en) | 2006-05-30 | 2007-12-13 | Incept, Llc | Materials formable in situ within a medical device |
EP2029217A4 (en) * | 2006-05-30 | 2012-09-26 | Incept Llc | Materials formable in situ within a medical device |
EP2029217A2 (en) * | 2006-05-30 | 2009-03-04 | Incept, LLC | Materials formable in situ within a medical device |
US11160557B2 (en) | 2006-06-15 | 2021-11-02 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US9451963B2 (en) | 2006-06-15 | 2016-09-27 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US10226258B2 (en) | 2006-06-15 | 2019-03-12 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US10499925B2 (en) | 2006-06-15 | 2019-12-10 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US9724103B2 (en) | 2006-06-15 | 2017-08-08 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US9259228B2 (en) | 2006-06-15 | 2016-02-16 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US9877731B2 (en) | 2006-06-15 | 2018-01-30 | Microvention, Inc. | Embolization device constructed from expansile polymer |
US11185336B2 (en) | 2006-06-15 | 2021-11-30 | Microvention, Inc. | Embolization device constructed from expansile polymer |
WO2009046281A2 (en) * | 2007-10-05 | 2009-04-09 | Boston Scientific Scimed, Inc. | Injectable particles |
WO2009046281A3 (en) * | 2007-10-05 | 2010-02-18 | Boston Scientific Scimed, Inc. | Injectable particles |
US9486221B2 (en) | 2007-12-21 | 2016-11-08 | Microvision, Inc. | Hydrogel filaments for biomedical uses |
US10194915B2 (en) | 2007-12-21 | 2019-02-05 | Microvention, Inc. | Implantation devices including hydrogel filaments |
US9114200B2 (en) | 2009-09-24 | 2015-08-25 | Microvention, Inc. | Injectable hydrogel filaments for biomedical uses |
US9993252B2 (en) | 2009-10-26 | 2018-06-12 | Microvention, Inc. | Embolization device constructed from expansile polymer |
EP2667855B1 (en) * | 2011-01-27 | 2017-08-09 | Biocompatibles Uk Ltd. | Drug delivery systems |
US9456823B2 (en) | 2011-04-18 | 2016-10-04 | Terumo Corporation | Embolic devices |
US9381278B2 (en) | 2012-04-18 | 2016-07-05 | Microvention, Inc. | Embolic devices |
EP4000639A1 (en) | 2013-09-06 | 2022-05-25 | Biocompatibles Uk Ltd. | Imageable polymers |
US10350295B2 (en) | 2013-09-06 | 2019-07-16 | Biocompatibles Uk Ltd. | Radiopaque polymers |
US10098972B2 (en) | 2013-09-06 | 2018-10-16 | Biocompatibles Uk Ltd. | Imageable polymers |
US10556022B2 (en) | 2013-09-06 | 2020-02-11 | Biocompatibles Uk Ltd. | Imageable polymers |
US10568967B2 (en) | 2013-09-06 | 2020-02-25 | Biocompatibles Uk Ltd. | Radiopaque polymers |
US10124090B2 (en) | 2014-04-03 | 2018-11-13 | Terumo Corporation | Embolic devices |
US10946100B2 (en) | 2014-04-29 | 2021-03-16 | Microvention, Inc. | Polymers including active agents |
US10092663B2 (en) | 2014-04-29 | 2018-10-09 | Terumo Corporation | Polymers |
US10226533B2 (en) | 2014-04-29 | 2019-03-12 | Microvention, Inc. | Polymer filaments including pharmaceutical agents and delivering same |
US11759547B2 (en) | 2015-06-11 | 2023-09-19 | Microvention, Inc. | Polymers |
US10639396B2 (en) | 2015-06-11 | 2020-05-05 | Microvention, Inc. | Polymers |
WO2017037276A1 (en) * | 2015-09-03 | 2017-03-09 | Biocompatibles Uk Limited | Polymers and microspheres |
CN107949376A (en) * | 2015-09-03 | 2018-04-20 | 生物兼容英国有限公司 | Polymer and microballoon |
EP3199186A1 (en) * | 2016-01-28 | 2017-08-02 | Cook Medical Technologies LLC | Injectable compositions and methods of use thereof |
CN107812232A (en) * | 2017-11-08 | 2018-03-20 | 华威(深圳)医疗器械有限责任公司 | Can be developed carboxy-modified polyvinyl alcohol microparticles suppository and its preparation technology |
US11730865B2 (en) | 2018-05-15 | 2023-08-22 | Incept, Llc | Embolic compositions and methods |
WO2020003147A2 (en) | 2018-06-29 | 2020-01-02 | Biocompatibles Uk Limited | Radiopaque polymers |
US11702498B2 (en) | 2018-06-29 | 2023-07-18 | Biocompatibles Uk Limited | Radiopaque polymers |
WO2023287727A1 (en) | 2021-07-12 | 2023-01-19 | Boston Scientific Scimed, Inc. | Radiopaque compositions |
WO2023122292A1 (en) | 2021-12-23 | 2023-06-29 | Boston Scientific Medical Device Limited | Chemoembolic compositions and methods of treatment using them |
Also Published As
Publication number | Publication date |
---|---|
AU4566001A (en) | 2001-09-24 |
US6676971B2 (en) | 2004-01-13 |
USRE48302E1 (en) | 2020-11-10 |
CA2403218A1 (en) | 2001-09-20 |
USRE47873E1 (en) | 2020-02-25 |
US20090209658A1 (en) | 2009-08-20 |
ATE373682T1 (en) | 2007-10-15 |
JP2003527402A (en) | 2003-09-16 |
AU2001245660B2 (en) | 2006-06-15 |
DE60130544D1 (en) | 2007-10-31 |
US20030223956A1 (en) | 2003-12-04 |
US8221735B2 (en) | 2012-07-17 |
US20010036451A1 (en) | 2001-11-01 |
EP1263803A1 (en) | 2002-12-11 |
CA2403218C (en) | 2011-10-18 |
EP1263803B1 (en) | 2007-09-19 |
USRE47121E1 (en) | 2018-11-13 |
DE60130544T2 (en) | 2008-06-26 |
JP4871476B2 (en) | 2012-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USRE48302E1 (en) | Embolic compositions | |
US20100074953A1 (en) | Methods for intiating in situ formation of hydrogels | |
EP1105180B1 (en) | Apparatus for intraluminal deposition of hydrogels | |
CA2402773C (en) | Tissue bulking and coating compositions | |
US7666339B2 (en) | Hydrogel string medical device | |
US6652883B2 (en) | Tissue bulking and coating compositions | |
WO2002072166A1 (en) | Compositions for drug delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001245660 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2403218 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 567808 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001918602 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2001918602 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001918602 Country of ref document: EP |